Virgil Abloh's Cardiac Angiosarcoma The fashion designer's death due to this rare form of cancer took the world by surprise Dec 15, 2021
Non-Invasive Nerve Stimulation Shows Promise for Younger IBD Patients Small pilot study found many children and young adults achieved clinical remission Dec 15, 2021
Gene Therapy Resolves Severe Pain Events in Sickle Cell Disease LentiGlobin also normalized hemoglobin and reduced hemolysis markers Dec 15, 2021
Year in Review: Crohn's Disease First interchangeable biosimilar approved, biologics go head-to-head Dec 15, 2021
Leveraging Digital Tech and Shared Decision-Making in PsA Care Our expert roundtable discusses patient-physician discordance and the need for tracking PROs Dec 15, 2021 video
Wide Racial Gap for Diabetes Tech Use Among Medicare Patients Insulin pump and CGM use significantly lower among black patients Dec 15, 2021
Day in the Life of a Doctor: Shadowing a NICU Nurse Practitioner Follow YouTuber Siobhan Deshauer, MD, on a tour of the neonatal intensive care unit Dec 14, 2021
What Do Alec Baldwin and the Unvaccinated Have in Common? Both carry "live rounds" that put people in harm's way Dec 14, 2021
For IBD Patients, Too Much Processed Meat May Be Deadly Study investigates diet's link to all-cause mortality, not just IBD incidence Dec 14, 2021
Can Dasatinib Dose Be Halved in Low-Risk CML? Lower dose associated with improved tolerability, similar responses in propensity score analysis Dec 14, 2021
CAR T-Cell Win Streak Stopped by Negative Trial in Aggressive LBCL Patients, trial design, logistics among possible explanations for lack of EFS benefit Dec 14, 2021
Fitusiran Prophylaxis Cuts Bleeding in Hemophilia A/B Monthly infusion vs on-demand bypassing agents effective in patients with or without inhibitors Dec 14, 2021
Real-World Treatment Preferences of Patients With Psoriatic Arthritis Olga Petryna, MD, explains the recent shift in medication patterns Dec 14, 2021 video
In the Story of Our Practice, We're Always the Hero When is it right to challenge our medical colleagues? Dec 14, 2021
Clinical Challenges: Chemoprevention for Early Breast Cancer Uptake low, but patient education and lower dosing can help Dec 14, 2021
R-CHOP Toppled in First-Line DLBCL Trial Replacing vincristine with polatuzumab vedotin improved PFS, without adding toxicity Dec 14, 2021
Nurse Who Got First COVID Shot in the U.S. Pushes for Greater Uptake A year later, Sandra Lindsay strives to sway "folks who are on the fence" about vaccination Dec 13, 2021
It's Not Rocket Science: Brain Surgeons May Be No Smarter Than Others Cognitive test scores attempt to settle an age-old argument Dec 13, 2021
Gentler Regimen Leads to High Response Rate in Older Patients With B-Cell ALL One-year OS rate of 78% with fractionated inotuzumab ozogamicin exceeds 60% historical rate Dec 13, 2021
β-Thalassemia Patients Go Transfusion-Free With Gene Therapy Treatment with beti-cel is "potentially curative" in this transfusion-dependent group Dec 13, 2021
Sugar-Sweetened Beverage Taxes Fizzled for Preventing Obesity in Kids Real-world study found only modest benefit for adolescent girls in Mexico Dec 13, 2021
R2 Maintenance for Elderly MCL Patients Worth the Risk? Longer PFS with addition of lenalidomide to rituximab, but also more toxicity Dec 13, 2021
There's More Than One Way to Treat Lipedema Surgery may not always be the best option, case report finds Dec 13, 2021
Empagliflozin Also Shows Benefit for 'True' HFpEF Patients Stefan Anker, MD, says it should be "the new paradigm" for treatment of patients with LVEF 50% Dec 13, 2021 video
Venetoclax Regimens for 'Fit' CLL Yield High Undetectable MRD Rates Combined with obinutuzumab, plus or minus ibrutinib, outperforms chemoimmunotherapy Dec 13, 2021
Clinical Challenges: Complications of CLL Side effects of novel treatments differ from those of traditional chemotherapy Dec 13, 2021
Post-Stroke Epilepsy Treatment May Influence Mortality All-cause death lowest in people taking lamotrigine Dec 13, 2021
Trastuzumab ADC Active in HER2-Low, HER2-Undetected Breast Cancer No clear explanation for responses to HER2-targeted drug in HER2-negative tumors Dec 12, 2021
Neratinib-Based Combo Shows Efficacy in HR+, HER2-Mutant Metastatic Breast Cancer Objective response rate of 42% in patients previously treated with CDK4/6 inhibitors Dec 12, 2021
Novel Bispecific Antibody Nets Durable Remissions in Follicular Lymphoma Mosunetuzumab offers "clinically meaningful outcomes" in relapsed/refractory disease Dec 12, 2021
Induction Isatuximab-RVd Combo Boosts MRD Negativity in Multiple Myeloma Half of newly diagnosed, transplant-eligible patients reached minimal residual disease negativity Dec 12, 2021
CAR T-Cell Therapy Makes Strong Case for Earlier Use in Lymphoma Large increases in event-free survival with two CAR T-cell products in second line Dec 11, 2021
More Bathroom Visits Tied To Social Impairments in Ulcerative Colitis Urgency deserves consideration as a UC-specific patient-reported outcome, researchers say Dec 11, 2021
Upfront IDH1 Inhibitor Triples Survival in Older AML Median OS for ivosidenib-azacitidine reached 2 years in patients ineligible for intensive therapy Dec 11, 2021
The Race to Find Uses for Big Data The concept has infiltrated healthcare, but is the information being used effectively? Dec 11, 2021
No Extra C. Diff Risk Observed With Vedolizumab in Ulcerative Colitis Retrospective study found no increased risk versus anti-TNF agents, but more research is needed Dec 11, 2021
Case of Parkinson's-Like Symptoms in Myeloma Patient After CAR-T Product FDA advises monitoring patients after T-cell infusion for signs, symptoms of neurotoxicity Dec 10, 2021
Controversial Doc No Longer With One of Idaho's Largest Health Networks Ryan Cole, MD, previously came under fire for spreading falsities about COVID vaccines, therapies Dec 10, 2021
